Lasa Supergenerics Share Price
Free Demat with Zero AMC*
+ Free 1st Year AMC
Summary
The stock has recorded a trading volume of 10,284 shares,. Its Average Traded Price (ATP) is ₹5.67, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 111 @ ₹5.67.
Lasa Supergenerics has an upper circuit limit of ₹5.95 and a lower circuit limit of ₹5.39. The total value traded stands at ₹58310.28, and the delivery percentage for the day is -1%.
The stock is currently traded with a market lot size of 1. Lasa Supergenerics also offers a dividend yield of 0%.
Lasa Supergenerics Share Price Chart
Lasa Supergenerics Share Key Metrics
Volume
10284.00
Market Cap
28.41 CR
LTQ@LTP
111@5.67
ATP
5.67
Var Margin
0 %
Circuit Range
5.39-5.95
Delivery %
- %
Value
58310.28
ASM/GSM
No
Market Lot
1
Lasa Supergenerics Resistance and Support
Pivot 5.68
Resistance
First Resistance
5.69
Second Resistance
5.71
Third Resistance
5.72
Support
First Support
5.66
Second Support
5.65
Third Support
5.63
Lasa Supergenerics Shareholding Pattern
View More- 2019-20
- 2020-21
- 2021-22
- 2022-23
- 2023-24
- 2025-26
- 2026-27
- 2024-25
- 2018-19
Total Promoters
Lasa Supergenerics News
Lasa Supergenerics Ltd - 540702 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Lasa Supergenerics Limited submitted the Consolidated Scrutinizer's Report for its 11th AGM held on September 30, 2026, confirming that all resolutions were passed with requisite majority.
Oct 01 2026 15:53:22
Lasa Supergenerics Ltd - 540702 - Notice Of The Annual General Meeting
Lasa Supergenerics board approved the re-appointment of Chairman & MD Omkar Herlekar and the appointment of Janardan Savala as a Whole-time Director. Key financial approvals included increased limits for charitable donations (up to Rs. 2 cr/annum), managerial remuneration (up to Rs. 3 cr/annum) even with inadequate profits, and enhanced borrowing powers.
Sep 09 2026 17:27:46
Lasa Supergenerics Ltd - 540702 - Board Meeting Outcome for Outcome Of The Baord Meeting
Lasa Supergenerics' board approved a proposal to seek shareholder approval for enhanced borrowing powers. The funds are intended mainly for the repayment of an alleged disputed external borrowing loan. This will allow the company to borrow beyond its paid-up capital and free reserves.
Sep 09 2026 17:09:25
Lasa Supergenerics Management
| Name | Position |
|---|---|
| Omkar Pravin Herlekar | Chairman & Managing Director |
| Ketan Bhau Songal | Non Executive Independent Director |
Lasa Supergenerics Similar Stocks
Samrat Pharmachem Ltd.
232.00
-9.70 (4.01%)
Aspira Pathlab & Diagnostics Ltd.
131.25
-6.53 (4.74%)
Lotus Eye Hospital And Institute Ltd.
116.45
0.45 (0.39%)
Star Imaging and Path Lab Ltd.
74.51
-2.49 (3.23%)
Parnax Lab Ltd.
115.00
3.50 (3.14%)
Alpa Laboratories Ltd.
59.99
0.45 (0.76%)
Raaj Medisafe India Ltd.
98.97
3.87 (4.07%)
Lasa Supergenerics FAQs
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in LASA
Account Opening Fee AMC for 1st Year Auto Square Off Charges Call & Trade
+ Free 1st Year AMC